The administration has proposed a 15% cap on indirect cost reimbursements for NIH funded research, an abrupt change that would throw US research capacity into turmoil. We need Congress to step in and ensure that any changes to indirect cost policies are made through a transparent, stakeholder-informed process rather than abrupt cuts that would halt innovation and slow medical progress. Tell your Members of Congress to oppose these cuts and protect America’s investment in research!

Note: Your contact information is collected to connect you to your representatives in Congress and enable them to respond to you directly.